Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 80,712 | 46,496 | 47,200 | 42,798 | 50,189 |
| Operating Income | -80,712 | -46,496 | -47,200 | -42,798 | -50,189 |
| Interest Expense | 4,213 | 3,521 | 4,535 | 1,443 | 4,736 |
| Other Income | -68,433 | 1,603 | -635 | 4,863 | -302 |
| Pre-tax Income | -153,358 | -48,414 | -52,370 | -39,378 | -55,227 |
| Net Income Continuous | -153,358 | -48,414 | -52,370 | -39,378 | -55,227 |
| Net Income | $-153,358 | $-48,414 | $-52,370 | $-39,378 | $-55,227 |
| EPS Basic Total Ops | N/A | -0.76 | -0.83 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -0.76 | -0.83 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.76 | -0.83 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -0.76 | -0.83 | N/A | N/A |
| EBITDA(a) | $-148,873 | $-44,642 | $-47,562 | $-37,656 | $-50,246 |